Dismiss Modal

Locations

Medical Office

WIC 1700 6th Ave S,
Suite 9100 176F
Birmingham , AL 35233

About Me

Education

Residency:
University of Alabama at Birmingham

Medical School:
University of North Carolina School of Medicine

Fellowship:
Baylor College of Medicine

Fellowship:
Medical University of South Carolina

Fellowship:
Texas Children’s Hospital

Internship:
University of Alabama at Birmingham

Board Certifications

Pediatrics, American Board of Pediatrics (1991)

Pediatric Cardiology, American Board of Pediatrics - Pediatric Cardiology (1996)

Special Interests

Dr. McMahon is Medical Director, Pediatric Cardiac Catheterization Laboratories, Children's of Alabama; Professor of Pediatrics, University of Alabama at Birmingham. He specializes in catheter treatments for infants, children and adults with congenital heart disease. Under his direct leadership, catheter based treatments have become available for many patients who previously required open surgical treatment. Patients now benefit from less invasive treatment techniques, which are associated with lower complication rates, shorter hospital stays, less discomfort, and reduced overall cost of treatment. These advantages all promote better outcomes for patients. Dr. McMahon has been an investigator in national, multi-center clinical trials that have investigated the safety and effectiveness of catheter based treatment, and led to the approval of devices for PDA closure and ASD closure.

Additional Resources

Special Interests

Dr. McMahon is Medical Director, Pediatric Cardiac Catheterization Laboratories, Children's of Alabama; Professor of Pediatrics, University of Alabama at Birmingham. He specializes in catheter treatments for infants, children and adults with congenital heart disease. Under his direct leadership, catheter based treatments have become available for many patients who previously required open surgical treatment. Patients now benefit from less invasive treatment techniques, which are associated with lower complication rates, shorter hospital stays, less discomfort, and reduced overall cost of treatment. These advantages all promote better outcomes for patients. Dr. McMahon has been an investigator in national, multi-center clinical trials that have investigated the safety and effectiveness of catheter based treatment, and led to the approval of devices for PDA closure and ASD closure.